Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 12 (6) , 1715-1721
Abstract
Background: There is limited consensus on whether metastatic patterns are correlated with prognosis and treatment efficacy in pancreatic cancer. A better understanding of clinical implication of the metastatic patterns is pivotal for therapeutic decision-making and drug development.Keywords
This publication has 25 references indexed in Scilit:
- Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic AdenocarcinomaAnnals of Surgery, 2017
- Pancreatic cancerThe Lancet, 2016
- Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal AdenocarcinomaDigestive Surgery, 2015
- Surgery for oligometastasis of pancreatic cancer2015
- Pulmonary metastases in pancreatic cancer, is there a survival influence?2015
- Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic CancerThe Oncologist, 2015
- Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 SensitivityJournal of Clinical Oncology, 2013
- Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancerEuropean Journal of Cancer, 2013
- The prognostic and predictive value of serum CA19.9 in pancreatic cancerAnnals of Oncology, 2012
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009